• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物混悬液湿搅拌介质研磨过程中温度随时间演变的焓平衡模型。

An Enthalpy-Balance Model for Timewise Evolution of Temperature during Wet Stirred Media Milling of Drug Suspensions.

机构信息

Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ, USA.

GlaxoSmithKline, Drug Product Development, GlaxoSmithKline, Collegeville, PA, 19426, USA.

出版信息

Pharm Res. 2022 Sep;39(9):2065-2082. doi: 10.1007/s11095-022-03346-3. Epub 2022 Aug 2.

DOI:10.1007/s11095-022-03346-3
PMID:35915319
Abstract

PURPOSE

Nanosuspensions have been used for enhancing the bioavailability of poorly soluble drugs. This study explores the temperature evolution during their preparation in a wet stirred media mill using a coupled experimental-enthalpy balance approach.

METHODS

Milling was performed at three levels of stirrer speed, bead loading, and bead sizes. Temperatures were recorded over time, then simulated using an enthalpy balance model by fitting the fraction of power converted to heat ξ. Moreover, initial and final power, ξ, and temperature profiles at 5 different test runs were predicted by power-law (PL) and machine learning (ML) approaches.

RESULTS

Heat generation was higher at the higher stirrer speed and bead loading/size, which was explained by the higher power consumption. Despite its simplicity with a single fitting parameter ξ, the enthalpy balance model fitted the temperature evolution well with root mean squared error (RMSE) of 0.40-2.34°C. PL and ML approaches provided decent predictions of the temperature profiles in the test runs, with RMSE of 0.93-4.17 and 1.00-2.17°C, respectively.

CONCLUSIONS

We established the impact of milling parameters on heat generation-power and demonstrated the simulation-prediction capability of an enthalpy balance model when coupled to the PL-ML approaches.

摘要

目的

纳米混悬剂已被用于提高难溶性药物的生物利用度。本研究采用耦合实验-焓平衡方法,探索在湿搅拌介质磨机中制备纳米混悬剂时的温度演变。

方法

在三种搅拌速度、珠载量和珠粒尺寸水平下进行研磨。记录随时间变化的温度,然后使用焓平衡模型通过拟合转化为热的功率分数 ξ 进行模拟。此外,通过幂律 (PL) 和机器学习 (ML) 方法预测了 5 个不同测试运行的初始和最终功率、ξ 和温度曲线。

结果

在较高的搅拌速度和珠载量/尺寸下,热量生成更高,这可以用较高的功率消耗来解释。尽管焓平衡模型只有一个拟合参数 ξ ,但其对温度演变的拟合非常好,均方根误差 (RMSE) 为 0.40-2.34°C。PL 和 ML 方法在测试运行中提供了相当好的温度曲线预测,RMSE 分别为 0.93-4.17°C 和 1.00-2.17°C。

结论

我们确定了研磨参数对产热-功率的影响,并展示了当与 PL-ML 方法耦合时焓平衡模型的模拟-预测能力。

相似文献

1
An Enthalpy-Balance Model for Timewise Evolution of Temperature during Wet Stirred Media Milling of Drug Suspensions.药物混悬液湿搅拌介质研磨过程中温度随时间演变的焓平衡模型。
Pharm Res. 2022 Sep;39(9):2065-2082. doi: 10.1007/s11095-022-03346-3. Epub 2022 Aug 2.
2
Analysis of heat generation during the production of drug nanosuspensions in a wet stirred media mill.湿磨搅拌介质中制备药物纳米混悬剂过程中的发热分析。
Int J Pharm. 2022 Aug 25;624:122020. doi: 10.1016/j.ijpharm.2022.122020. Epub 2022 Jul 14.
3
Predicting the Temperature Evolution during Nanomilling of Drug Suspensions via a Semi-Theoretical Lumped-Parameter Model.通过半理论集总参数模型预测药物悬浮液纳米研磨过程中的温度演变
Pharmaceutics. 2022 Dec 18;14(12):2840. doi: 10.3390/pharmaceutics14122840.
4
A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.通过湿式搅拌介质研磨制备药物纳米混悬液时选择珠粒尺寸的微流体动力学原理。
Int J Pharm. 2017 May 30;524(1-2):178-192. doi: 10.1016/j.ijpharm.2017.04.001. Epub 2017 Apr 2.
5
Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.工艺参数对难溶性药物在湿搅拌介质研磨过程中破碎动力学的影响:微观流体动力学视角
Eur J Pharm Sci. 2014 Jan 23;51:75-86. doi: 10.1016/j.ejps.2013.09.002. Epub 2013 Sep 12.
6
An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.一种强化振动研磨工艺,用于提高药物纳米混悬液制备过程中的破碎动力学。
AAPS PharmSciTech. 2016 Apr;17(2):389-99. doi: 10.1208/s12249-015-0364-3. Epub 2015 Jul 17.
7
Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs.在药物湿磨过程中,介质材料和工艺参数对破损动力学和能量消耗的影响。
Eur J Pharm Biopharm. 2020 Aug;153:52-67. doi: 10.1016/j.ejpb.2020.05.024. Epub 2020 Jun 6.
8
Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.湿磨搅拌介质法制备药物纳米混悬剂的机理建模。
AAPS PharmSciTech. 2020 Nov 22;22(1):2. doi: 10.1208/s12249-020-01876-w.
9
Do Mixtures of Beads with Different Sizes Improve Wet Stirred Media Milling of Drug Suspensions?不同尺寸珠子的混合物能否改善药物悬浮液的湿式搅拌介质研磨?
Pharmaceutics. 2023 Aug 26;15(9):2213. doi: 10.3390/pharmaceutics15092213.
10
Use of Bead Mixtures as a Novel Process Optimization Approach to Nanomilling of Drug Suspensions.使用珠粒混合物作为一种新颖的纳米悬浮液药物处理过程优化方法。
Pharm Res. 2021 Jul;38(7):1279-1296. doi: 10.1007/s11095-021-03064-2. Epub 2021 Jun 24.

引用本文的文献

1
Development of a Semi-Mechanistic Modeling Framework for Wet Bead Milling of Pharmaceutical Nanosuspensions.用于药物纳米混悬液湿珠磨的半机理建模框架的开发
Pharmaceutics. 2024 Mar 13;16(3):394. doi: 10.3390/pharmaceutics16030394.
2
Do Mixtures of Beads with Different Sizes Improve Wet Stirred Media Milling of Drug Suspensions?不同尺寸珠子的混合物能否改善药物悬浮液的湿式搅拌介质研磨?
Pharmaceutics. 2023 Aug 26;15(9):2213. doi: 10.3390/pharmaceutics15092213.
3
Predicting the Temperature Evolution during Nanomilling of Drug Suspensions via a Semi-Theoretical Lumped-Parameter Model.

本文引用的文献

1
Exploring the influence factors and improvement strategies of drug polymorphic transformation combined kinetic and thermodynamic perspectives during the formation of nanosuspensions.探讨纳米混悬剂形成过程中药物多晶型转变的影响因素及改善策略——从动力学和热力学角度。
Drug Dev Ind Pharm. 2021 Dec;47(12):1867-1880. doi: 10.1080/03639045.2022.2061988. Epub 2022 Apr 14.
2
Kinetic and Microhydrodynamic Modeling of Fenofibrate Nanosuspension Production in a Wet Stirred Media Mill.在湿式搅拌介质磨中制备非诺贝特纳米混悬液的动力学和微流体动力学建模
Pharmaceutics. 2021 Jul 10;13(7):1055. doi: 10.3390/pharmaceutics13071055.
3
通过半理论集总参数模型预测药物悬浮液纳米研磨过程中的温度演变
Pharmaceutics. 2022 Dec 18;14(12):2840. doi: 10.3390/pharmaceutics14122840.
Use of Bead Mixtures as a Novel Process Optimization Approach to Nanomilling of Drug Suspensions.
使用珠粒混合物作为一种新颖的纳米悬浮液药物处理过程优化方法。
Pharm Res. 2021 Jul;38(7):1279-1296. doi: 10.1007/s11095-021-03064-2. Epub 2021 Jun 24.
4
Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.湿磨搅拌介质法制备药物纳米混悬剂的机理建模。
AAPS PharmSciTech. 2020 Nov 22;22(1):2. doi: 10.1208/s12249-020-01876-w.
5
Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs.在药物湿磨过程中,介质材料和工艺参数对破损动力学和能量消耗的影响。
Eur J Pharm Biopharm. 2020 Aug;153:52-67. doi: 10.1016/j.ejpb.2020.05.024. Epub 2020 Jun 6.
6
Comprehensive quality by design approach for stable nanocrystalline drug products.采用全面质量设计方法制备稳定的纳米晶药物产品。
Int J Pharm. 2019 Jun 10;564:426-460. doi: 10.1016/j.ijpharm.2019.04.050. Epub 2019 Apr 23.
7
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.基于质量源于设计的硝苯地平纳米混悬剂的研制:考察制剂变量、湿磨工艺参数和辅料变异性对药物产品质量属性的相对影响。
Drug Dev Ind Pharm. 2018 Dec;44(12):1942-1952. doi: 10.1080/03639045.2018.1503296. Epub 2018 Oct 12.
8
Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.湿磨灰黄霉素纳米混悬剂的多面特性研究,阐明其聚集状态和稳定机制。
AAPS PharmSciTech. 2018 May;19(4):1789-1801. doi: 10.1208/s12249-018-0993-4. Epub 2018 Mar 30.
9
Temperature-Induced Surface Effects on Drug Nanosuspensions.温度诱导的药物纳米混悬剂表面效应。
Pharm Res. 2018 Feb 21;35(3):69. doi: 10.1007/s11095-017-2300-6.
10
Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling.通过湿磨介质研磨法优化卡维地洛纳米混悬剂的制剂和工艺参数。
Int J Pharm. 2018 Apr 5;540(1-2):150-161. doi: 10.1016/j.ijpharm.2018.02.011. Epub 2018 Feb 10.